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Phospholipids are widely used as structural amphiphilic
compounds in liposome formulations. In this study, we have
analyzed the interaction the sodium diclofenac (SD) with soya
phosphaditylcholine (PC) and soya phosphatidylcholine from
lyophilized small unilamellar liposomes (SUV). The changes in
the properties of the co-lyophilized drug/PC from SUV liposomes,
lyophilized PC from SUV liposomes, and lyophilized soya
phosphatidylcholine, were studied by Differential Scanning
Calorimetry (DSC). The DSC data showed that the previous
organization of phospholipids molecules to form liposome affects
intensely the thermal behavior of PC when compared to non-
lipossomal PC. SD modified the thermal properties of PC from
liposomes. It was verified that SD affects intensely the located
group peaks in the regions of 120-140 °C and in the higher
temperature region of 240-260 °C. The results of this work
demonstrated that the presence of the drug modified the DSC
behavior for both liposomal and non-liposomal PC and that these
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benzeneacetic acid) is a non-steroidal anti-inflammatory
drug with good analgesic properties; however it may cau-
ses side effects including gastrointestinal disorders when
administered by oral route and cutaneous lesion by
intramuscular injection (Giovannetti et al., 1993).
Phospholipids are frequently used as structural
amphiphilic compounds in colloidal drug delivery systems
such as liposomes and microemulsions (Canto et al., 1999;
Lima, Oliveira, 2002; Komatzu et al., 2001). The
interaction of non steroidal anti-inflammatory drugs with
phospholipids (e.g. phosphatidylcholine (PC)) is of
importance in the pharmaceutical field due to modification
of bioavailability improving the drug efficacy
(Lichtenberger et al., 1996a, b) and to decrease side effects
(Lichtenberger et al., 1995; Schutze, Muller-Goymann,
1998).
Liposomes are colloidal supramolecular aggregates
frequently used as drug carriers for a wide range of drugs
including analgesics and anti-inflammatories (Canto et
al., 1999; Lima, Oliveira, 2002; Lasic, 1997; Venema,
Weringa, 1987; Bermúdez et al., 1999; Lima et al.,
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2001). However, in spite of the properties highly
biocompatible of the phosphatidylcholine that can protect
the local tissue from the side effects of the anti-
inflammatory drug (Lima, Oliveira, 2002 ), PC is not
sufficiently stable in aqueous medium and decomposes by
hydrolysis and oxidation (New, 1997). Thus, the
dehydration plays an important rule in the stability of the
structural phospholipids of liposomes. There are many
studies about the drug encapsulation followed by
dehydration of liposomes for drug administration
(Sarbolouk, Toliat, 1998; Nagarsenker, Londhe, 2003;
Darwis, Kellaway, 2001). Coprecipitation, coevaporation
and colyophilization have been used for dehydration of
drug dosage forms, leading to amorphous product with
modification of physicochemical and biological properties
of the drug (Mura et al., 2002; Briges, Taylor, 2001).
DSC has been used as a useful tool in drug analysis to
access information about drug-drug and drug-excipient
interactions (van Windenn et al., 1998; Adeyeye, Price, 1991),
molecular complexation (Souza et al., 2002; Medeiros et al.,
2002; Bettinetti et al., 1992; Castelli et al., 1992) and
materials stability and compatibility ( Medeiros et al., 2002;
Coffin, McGinnity, 1992; Koenignauer et al., 1992; Torricelli
et al., 1991) in pharmaceutical formulations. The modification
of the physicochemical properties of dehydrated drug/lipid
systems also can be easily accessed by DSC analysis
(Bermúdez et al., 1999; Kinigt, 1981; Biltonen, Lichtenberg,
1993; Castelli, et al., 2001; van Winden et al., 1997; Sanches-
Migallon et al., 1996; Rodante et al., 2002).
In this work empty SUV structured with PC and SUV
containing sodium salt of diclofenac were obtained. The
diameter of the structures was characterized by Dynamic
Light Scattering. The amorphous product derived from
lyophilization was analyzed by DSC in order to verify the
differences in the properties of PC, PC previously
structured in the liposomes and the effect of both acid
diclofenac and sodium diclofenac on these properties.
MATERIAL AND METHODS
Material
Soya phosphatidylcholine (PC), Epikuron 200®
(minimum 92% of PC, molecular weight 758.07), was
purchased from Degussa Texturants Systems Deutschland
GmbH & Co. (Hamburg, Germany). Analytical grade
chloroform, hydrochloric acid min. 37%, and ethyl alcohol
(Merck Darmstadt, F.R. Germany), sodium diclofenac
(SD) (Biogalenica, Brazil), Tris (hydroxymethyl)
aminomethane (Sigma Chemical Co, St Louis, USA) were
used as received. All other reagents were analytical grade.
Methods
Liposome Preparation
Liposomes containing 40 mM of soya phospha-
tidylcholine (PC) were prepared in 10 mM Tris-HCl buffer,
pH 7.2 by sonication as previously described (Canto et al.,
1999; Lima, Oliveira, 2002; Lima et al., 2001). A solution
containing 160 mM (121.3 mg/mL) of PC was prepared in
chloroform. 1 mL of the solution was placed in a sonication
tube and the organic solvent was eliminated under N2
stream in order to obtain a lipid film in the inner of tube.
The film was kept under vacuum for 2 h to remove the
solvent traces.
For films containing sodium diclofenac a solution of
31.6 mM (40 mg/mL) was prepared in ethanol. 1 mL of SD
solution was added to equal volume of phosphatidylcholine
solution and then the solvent was removed under N2 stream.
The dry lipid films with and without drug were
hydrated at 25 °C room controlled temperature for 45 min
with 4 mL of Tris-HCl buffer or SD buffered solution in
order to obtain the concentrations and final PC/SD ratios
described in Table I. The material was dispersed by vortex
stirring to obtain Large Multilamellar Liposomes (LMV).
Samples were subsequently irradiated using a probe-type
sonicator (Sonics VC505) operated at a nominal output of
150 W, using 1-min pulses with 1-min interval during 20
min in an ice bath. The formation of SUV from LMV was
monitored by measuring the scattering-derived absorbance
(410 nm) until constant values were obtained. Table I
summarizes the preparations used in the different
experiments of this work.
Non-liposomal mixtures preparation
A solution containing 160 mM (121.3 mg/mL) of PC
was prepared in chloroform. A solution containing
31.6 mM (40 mg/mL) of SD was prepared in ethanol.
Equal volumes of SD and PC solutions were mixed in order
to obtain the same molar ratio PC/SD of the liposomal
preparations (Table I). Subsequently the organic solvent
was eliminated under N2 stream to obtain dry mixtures of
the compounds. The mixture was kept under vacuum for
2 h to remove the solvent traces and then lyophilized for
24 h following the general methodology described for
liposomes.
Liposomes Lyophilization
For freeze-drying 4 mL of the liposomes dispersion
were put in 10 mL vials and quickly prefrozen in liquid
nitrogen. The vials were placed together in a tray dryer and
the water content was sublimated by 24 h using an Edwards
Mod. Modulyo apparatus. During all process the
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temperature and pressure were maintained at -40 °C and
0.13 mBar, respectively. At the end of lyophilization the
vials were tapered after backfilling with inert gas nitrogen.
Dynamic Light Scattering
The diameters were measured for empty liposomes and
diclofenac-load liposomes (see Table I). The dispersions
were filtered with a 0.22 mm polycarbonate membrane in
order to ensure dust-free samples, and diluted to 1:3 and 1:6
using 10 mM Tris-HCl buffer. The size distribution was
determined directly on the aqueous dispersion at 25 °C by
Dynamic Laser Light Scattering using a Brookhaven
apparatus with BI-9000 digital correlator and particle sizing
software from Brookhaven. The samples were analyzed at
90° and as light source was applied a 35 mW Spectra
Physics He-Ne laser, model 127, λ = 632.8 nm.
Differential Scanning Calorimetry (DSC)
The calorimetric analysis was performed in order to
determine the differences in the properties of PC and PC
previously structured in the liposome bilayer and the effect
of the sodium diclofenac on these properties. For this,
empty liposomes and liposomes containing drug
concentrations according Table I were prepared. Sodium
diclofenac, non-liposomal PC and mixtures of PC/SD at
molar ratio of 5.06 were also analyzed. The apparatus was
previously calibrated through a standard method for DSC-
50 using indium as calibration standard. The samples were
packed in aluminum cells and the used mass was 2 mg. The
DSC curves were recorded using a Shimadzu DSC-50
calorimeter oven with a temperature range of 25-500 °C,
under dry nitrogen atmosphere at constant flow of
50 mL/min and a heating rate of 10 °C/min. Empty
aluminum cell with a lid was used as reference.
Optical Microscopy
The optical microscopy as carried out using a Digi-
tal Melting Point SMP3 Apparatus from Stuart Scientific
(U.K.). The samples were placed in capillary tubes, the
temperature adjusted in the range of ambient to 300 °C, and
heating ramp rate programmed to 2 °C per min. Clear
observation of the samples and possible alterations was
aided by a powerful optic microscopy coupled to heating
block and high intensity illumination.
RESULTS AND DISCUSSION
The encapsulation of diclofenac in liposomes modified
the time for the decrease of the absorbance derived from light
scattering of the dispersion when multilamellar liposomes
were sonicated to obtain small unilamellar structures.
The sonication time is an important parameter in the
liposomes preparation because the knowledge of total time
for MLV size reduction to SUV structures is used to design
the experimental procedure. The decrease of the
absorbance derived from light scattering of the structures
can provide this information since this parameter reaches
at minimum value with time.
In the data of Figure 1 is shown that the scattering-
derived absorbance (410 nm) for the downsize of the
multilamellar liposomes in order to obtain unilamellar
structures decreases rapidly in the presence of SD reaching
at minimal constant values at least of 10 min. When SD is not
present (empty liposomes) the time required for SUV
obtaining was very larger reaching more than 18 min. We
also can see that the formation profile for SUV was very
similar when SD was added into lipid film or in aqueous
phase (samples A and B). Moreover there were not
significant differences in the obtained profiles when SD was
TABLE I - Liposome formulations used in the DSC analysis
Sample SD in film SD in lipid Total diclofenac Molar ratio PC/ Experimental
hydration film (mM) (mM) Total SD pH
Empty SUV 4 ml of Tris-HCl
buffer —- —- —- 7.21
A 4 ml of Tris-HCl
buffer 7.9  7.9 5.06 7.25
B 4 ml of buffered
7.9 mM SD
solution —- 7.9 5.06 7.30
C 4 ml ofbuffered
15.8 mM SD
solution 7.9 23.7 1.69 7.35
Phosphatidylcholine 40 mM, Tris-HCl buffer 10 mM, pH 7.2. SD=sodium diclofenac
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added in both, aqueous and lipid phases and the
concentration were increased three times. These phenomena
suggest that the ionic drug can be easily incorporated into
bilayer due predominantly to the hydrophobic effect.
The encapsulation of sodium diclofenac in liposomes
decreased the diameter of the liposomes from 57.8 nm to
41.8 nm by the addition of SD directly into lipid phase
(sample A). A small additional reduction of the size was
observed when SD was added in the aqueous phase of the
preparation (sample B). However, the largest decrease in
the liposome size was verified when SD was added
simultaneously in both aqueous and lipid phases and the
total drug concentration were increased three times (sample
C, Tables I and II). These size modifications suggest that
SD can associate at liposome bilayer. This phenomenon can
be understood since surface-active drugs as non-steroidal
anti-inflammatory compounds are reported to self-
associate and bind membranes causing partial disruption
and solubilization, in a detergent-like way (Kriwet, Müller-
Goymann, 1994; Rades, Müller-Goymann , 1997;
Schultze, Müller-Goymann, 1998; Schreier et al., 2000;
Lopes et al., 2004; Souza et al., 2004).
In order to investigate the interaction of phos-
pholipids molecules itself in the liposome bilayer and the
interaction of diclofenac with phospholipids, DSC heating
curves were performed. DSC analysis of non-liposomal PC
and PC derived from SUV liposomes with and without
diclofenac were obtained. This procedure allows assessing
the possible differences in the DSC profile of non-liposomal
PC, PC from liposomes and the effect of SD in the
phospholipid thermal behavior.
The results of Figure 2 suggest that the DSC curve of
PC can be dependent on the previous organization of PC
molecules to form liposome bilayer. In fact, Figure 2 shows
that the DSC heating curves of non-liposomal PC (Figure 2,
curve a) was very different from PC liposomes derived (Fi-
gure 2, curve b). The DSC curves for non-liposomal PC
showed a major group of peaks in the region 159-193, 267,
330, 340, 381 and 449 °C, whereas for PC from freeze-dried
liposomes the peaks appeared only at 243 and 448 °C. Great
difference in the DSC profile can be observed because the
decomposition of non-liposomal begins at about 140 °C,
while for the liposomal PC the main temperature range for
decomposition appears after the 220 °C. In fact, the DSC
analysis shows that for PC from dehydrated liposomes
different structures from non-liposomal PC can exist in the




Empty liposomes 57.8 ± 0.386
Sample A 41.8 ± 0.479
Sample B 39.4 ± 0.129
Sample C 31.8 ± 0.118
Phosphatidylcholine 40 mM; Tris-HCl buffer, 10 mM, pH
7.2. See Table I for samples details
FIGURE 2 - DSC heating curves of phosphatidylcholine.
Key: (a) freeze-dried non-liposomal soya phosphatidyl-
choline; (b) freeze-dried empty liposomes of soya
phosphatidylcholine.
FIGURE 1 - Effect of sonication time on the absorbance
derived from light scattering by MLV to obtain SUV. Key:
 empty liposomes containing phosphatidylcholine
40 mM1;  7.9 mM of SD added to aqueous phase;
 7.9 mM of SD added to lipid film;  23.7 mM of SD
added to aqueous and lipid phases. The data represents the
mean of triplicate experiments.
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medium. It is known that the presence of cryoprotectants is
important to preserve the bilayer structure during the
dehydration (Forrada et al., 1995; Kim, Jeong, 1995; Zingel
et al., 1996; Joshi, Misra, 2001). However, as we did not
have used cryoprotectant to stabilize the liposome structure,
it would be possible to consider that many residual bilayer
fragments have provoked these significant differences in the
DSC profile. Nevertheless, in this temperature region the
hydrophobic effect for organization of PC molecules in the
bilayer residues can not be significant. Finally it is
appropriate to highlight that while the DSC profile of the
non-liposomal PC seems to be an amorphous material, the
DSC profile of liposomal PC resembles a more organized
material in which the decomposition was characterized by an
intense peak at 243 °C (Figure 2).
The DSC curve of pure SD showed two endothermic
peaks at 52 and 78 °C and a group of peaks at 290, 300 and
345 °C produced by the drug decomposition (Figure 3, curve
a) and is in agreement with the data of literature (Giordano,
et al., 2003). The peaks at 141 °C for empty liposomes (Fi-
gure 3, curve b) can be related to phase transition from
amorphous solid to liquid product, appeared shifted to lower
temperature (125 °C) when SD was added to the lipid phase
during the liposome preparation (Figure 3, curve c) and
decreased significantly the peak intensity at 245 °C due to
product decomposition (Figure 3, curve c). This DSC behavior
can be explained since the sodium diclofenac can interacts with
phosphatidylcholine during the preparation of the liposomes
decreasing both the drug decomposition temperature and the
peak intensity related to drug decomposition at 245 °C.
The profile of phosphatidylcoline from liposomes
containing sodium diclofenac in the aqueous phase (Figure 4,
curve c) was different from that obtained for phospha-
tidylcholine from empty liposomes (Figure 4, curve b). In the
presence of SD the DSC curve was characterized by an
endothermic peak at 125 °C (Figure 4, curve c) which does not
exist for PC from empty liposomes. This data suggests that SD
interacts with lipid phase even when the drug is added to
aqueous phase of the liposomes that is in agreement with the
low water solubility of the sodium diclofenac.
On the other hand, the liposomes were obtained using
Tris-HCl buffer, which was freeze dried together with
liposomes structures. It would be reasonable to consider the
buffer as PC impurity, which could influence partially these
differences in DSC curves. However, Figure 5 shows clearly
that the peak in the region of 125 °C appears when the SD was
mixed to non-liposomal phosphatidylcholine (Figure 5, curve
b). This group of data demonstrates that the phenomenon
seems to be directly related with the interation between sodium
diclofenac and phosphatidylcholine molecules and not with the
possible presence of bilayer residues or Tris salt in the
phospholipid mixture.
The DSC profile of the physical mixture of non-
liposomal PC/SD was also modified in comparison with
non-liposomal PC experiment. The data shows an intense
peak at 120 due to phase transition of amorphous viscous
to liquid transparent gel and another at 225 °C related to
drug decomposition (Figure 5, curve b). This feature can be
easily seen by optical microscopy, through a capillary di-
FIGURE 3 - Effect of sodium diclofenac on the DSC
heating curves of phosphatidylcholine liposomes. Key: (a)
sodium diclofenac, (b) freeze-dried empty liposomes, (c)
freeze-dried liposomes containing sodium diclofenac added
to lipid phase (molar ratio PC/SD = 5.06).
FIGURE 4 - Effect of sodium diclofenac on the DSC
heating curves of phosphatidylcholine liposomes. Key: (a)
sodium diclofenac, (b) freeze-dried empty liposomes, (c)
freeze-dried liposomes containing sodium diclofenac added
to aqueous phase (Molar ratio PC/SD = 5.06).
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gital melting point apparatus. The curves of thermal
behavior of non-liposomal PC mixed with SD showed
peaks with the large intensity of the signal in the region of
120 °C, demonstrating that SD molecules interact with
phosphatidylcholine even in the dehydrated state.
CONCLUSION
The obtained data demonstrates that previous
organization of PC molecules to form liposomes affects
significantly the DSC profile of the PC from freeze-dried
liposomes when compared to non-liposomal PC. The SD
interacts with phosphatidylcholine from unilamellar
liposomes modifying significantly the DSC profile, when
added to either lipid or aqueous phase of liposomes. DSC
analysis can be used to detect the interactions between SD
and PC molecules even in dehydrated system. These results
indicate that in all cases the differences verified in the DSC
profile can be easily monitored through DSC analysis.
RESUMO
Interação do diclofenaco com fosfatidilcolina de soja e
lipossomas unilamelares liofilizados
Fosfolipídios são freqüentemente usados como compostos
anfifílicos estruturais em formulações de lipossomas. Neste
estudo foi analisada a interação do diclofenaco sódico (SD)
com a fosfatidilcolina de soja liofilizada e a fosfatidilcolina
de soja (PC) obtida de lipossomas unilamelares pequenos
liofilizados (SUV). As modificações nas propriedades da
mistura fármaco/PC co-liofilizados a partir de SUV pré-for-
mados, lipossomas de PC vazios e PC liofilizada foram es-
tudadas por Calorimetria Diferencial de Varredura (DSC).
Os resultados de DSC mostraram que a organização prévia
das moléculas PC para formar lipossomas interfere signifi-
cativamente no perfil de DSC da PC, quando comparada ao
perfil de DSC da PC não-lipossômica. Verificou-se que o SD
afeta intensamente o grupo de picos situados nas regiões de
120-140 °C e na região de mais alta temperatura (240-
260 °C). Os resultados deste trabalho demonstraram que em
todos os casos a presença do fármaco modificou o perfil de
DSC da PC e que essas modificações podem ser facilmanete
monitoradas através da análise de DSC.
UNITERMOS: Lipossomas. Diclofenaco. Fosfatidilcolina.
Liofilização. Calorimetria diferencial de varredura.
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